Biosafety and immunology: An interdisciplinary field for health priority
Authors:
Open Access
- 14 July 2024
- journal article
- review article
- Published by Elsevier in Biosafety and Health
- Vol. 6 (5) , 310-318
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2022YFC2604100)
- National Natural Science Foundation of China (82241072)
This publication has 96 references indexed in Scilit:
- A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal deliveryScience China Life Sciences, 2023
- Biomaterials That Induce Immunogenic Cell DeathSmall Methods, 2023
- Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenicFrontiers of Medicine, 2021
- The approved gene therapy drugs worldwide: from 1998 to 2019Biotechnology Advances, 2020
- It’s not just science: Challenges for public health intervention in Ebola epidemics in the Democratic Republic of CongoScience China Life Sciences, 2020
- Immune evasion by adenoviruses: a window into host–virus adaptationFEBS Letters, 2019
- The triphibious warfare against virusesScience China Life Sciences, 2017
- Human T-cell immunity against the emerging and re-emerging virusesScience China Life Sciences, 2017
- T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoVAntiviral Research, 2017
- HLA allele selection for designing peptide vaccinesGenetic Analysis: Biomolecular Engineering, 1996